- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.09. | Lilly unveils 1st of 4 new US manufacturing sites with $5B Virginia API plant | ||
| 16.09. | Dr. Reddy's India biologics plant issued FDA Form 483 | ||
| 15.09. | HHS taps 5 new members for CDC vaccine panel ahead of this week's meeting | ||
| 15.09. | Corstasis scores FDA nod for nasal spray treatment, touts sales potential | ||
| 15.09. | From the press box: Messages of resilience, authenticity resonated at Fierce Pharma Week 2025 | ||
| 15.09. | FDA's Marty Makary deems DTC drug advertising 'a public health crisis' in JAMA editorial | ||
| 15.09. | BMS sells controlling stake in historic US-China pharmaceutical joint venture | ||
| 15.09. | Fiercest Women in Life Sciences 2025: Nominations open now-TWO WEEKS LEFT | ||
| 12.09. | 'Keep doing what you're doing': Marketing policy experts unfazed by threats to DTC drug advertising | ||
| 12.09. | Trump officials eye connection between COVID shots, child deaths ahead of ACIP meeting: WaPo | ||
| 12.09. | Chronic disease treatment ads have sparked action in two-thirds of patients: survey | ||
| 12.09. | Gilead prevails in whistleblower lawsuit over alleged hepatitis C prescription kickbacks | ||
| 12.09. | Appeals court knocks back Novartis' IRA challenge one week after rejecting bid by BMS, J&J | ||
| 11.09. | Amid restructuring, Novo Nordisk directs employees to return to office | ||
| 11.09. | AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037 | ||
| 11.09. | Intercept, after many setbacks, pulls liver disease drug Ocaliva in US | ||
| 11.09. | Despite being designed for seniors, Merck's pneumococcal shot shows potential in children | ||
| 11.09. | FibroGen pays SEC $1.2M over allegations former exec 'reverse engineered' roxadustat data | ||
| 11.09. | Chicago private equity firm inks €4.1B purchase of former Sanofi generics unit Zentiva: FT | ||
| 11.09. | Sun's Gujarat facility put on FDA import alert for persistent production shortfalls | ||
| 11.09. | Sanofi, Gilead, Acadia win big at the 2025 Fierce Pharma Marketing Awards | ||
| 11.09. | API maker Hikal hit with FDA warning letter after repeat contamination complaints | ||
| 10.09. | Editor's Corner-For the first PD-1xVEGF's sake, Summit must submit to Big Pharma, stat | ||
| 10.09. | For pharmas looking to 'break through the clutter' and reach patients, relatability is the key | ||
| 10.09. | 'Land mines everywhere': How pharma communications keep up under a political spotlight |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .